These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis. Kankanala J; Latham AM; Johnson AP; Homer-Vanniasinkam S; Fishwick CW; Ponnambalam S Br J Pharmacol; 2012 May; 166(2):737-48. PubMed ID: 22141913 [TBL] [Abstract][Full Text] [Related]
28. Sophoridine suppresses lenvatinib-resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression. Zhao Z; Zhang D; Wu F; Tu J; Song J; Xu M; Ji J J Cell Mol Med; 2021 Jan; 25(1):549-560. PubMed ID: 33210432 [TBL] [Abstract][Full Text] [Related]
29. Biochemical characterization of a novel type-II VEGFR2 kinase inhibitor: comparison of binding to non-phosphorylated and phosphorylated VEGFR2. Iwata H; Imamura S; Hori A; Hixon MS; Kimura H; Miki H Bioorg Med Chem; 2011 Sep; 19(18):5342-51. PubMed ID: 21885287 [TBL] [Abstract][Full Text] [Related]
30. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy. Ichikawa K; Watanabe Miyano S; Minoshima Y; Matsui J; Funahashi Y Sci Rep; 2020 Feb; 10(1):2939. PubMed ID: 32076044 [TBL] [Abstract][Full Text] [Related]
31. VEGFR2 inhibition hampers breast cancer cell proliferation Ni H; Guo M; Zhang X; Jiang L; Tan S; Yuan J; Cui H; Min Y; Zhang J; Schlisio S; Ma C; Liao W; Nister M; Chen C; Li S; Li N Cancer Biol Med; 2021 Feb; 18(1):139-154. PubMed ID: 33628590 [TBL] [Abstract][Full Text] [Related]
32. Microtubule-targeted drugs inhibit VEGF receptor-2 expression by both transcriptional and post-transcriptional mechanisms. Meissner M; Pinter A; Michailidou D; Hrgovic I; Kaprolat N; Stein M; Holtmeier W; Kaufmann R; Gille J J Invest Dermatol; 2008 Aug; 128(8):2084-91. PubMed ID: 18323785 [TBL] [Abstract][Full Text] [Related]
33. Structural investigation of the VEGF receptor interaction with a helical antagonist peptide. Diana D; Di Stasi R; De Rosa L; Isernia C; D'Andrea LD; Fattorusso R J Pept Sci; 2013 Apr; 19(4):214-9. PubMed ID: 23420665 [TBL] [Abstract][Full Text] [Related]